FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.

H. Palmedo,Horst Urbach,Hans Bender,U. Schlegel,Ingo G.H. Schmidt-Wolf,Alexander Matthies,Michael Linnebank,Alexius Y. Joe,Jan Bucerius,H.-J. Biersack,H Pels

FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.

2006

H. Palmedo
Horst Urbach
Hans Bender
U. Schlegel
Ingo G.H. Schmidt-Wolf
Alexander Matthies
Michael Linnebank
Alexius Y. Joe
Jan Bucerius
H.-J. Biersack
H Pels

Purpose The role of FDG-PET in primary central nervous system lymphoma (PCNSL) is unclear. It was the aim of this study to investigate the role of FDG-PET in detecting PCNSL and in predicting response to chemotherapy.

Keywords:

Pathology
Minimal residual disease
Medicine
Radiology
Primary central nervous system lymphoma
Chemotherapy
therapeutic monitoring

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

100

Citations